ThetaPal ThetaPal

Manufacturing / Pharmaceutical Preparations

Genprex, Inc.

GNPX

$2.83

+$0.08 (+2.73%)

Price as of Oct 9, 2026 16:13 UTC

3.3 M

Market Cap (Micro Cap)

Nov 12

Next Earnings

Technical Signals as of Oct 7
Bearish
0 of 7

Trend

  • Above 20-day average $3.10
  • Above 50-day average $3.36
  • Above 200-day average $2.98 · -12.0%
  • Moving averages stacked Not aligned

Momentum

  • Golden cross (50/200) 52d ago
  • Momentum cross (20/50) Down · 9d ago

Volume

  • Below-average volume 0.9x avg

Price & Trend

Daily candles with EMA 20, SMA 50. Drag to zoom.

Options Heat Map

Delta-risk grid for GNPX options across strikes and expirations. Hover any cell for full Greeks.

Loading option chain data...

Insider Trades

0 buys 2 sells
Date Insider Title Type Shares Value Since Trade
Apr 14, 2026 LONGNECKER BRENT M Other 8 $10 +123.6%
Apr 14, 2026 LONGNECKER BRENT M Sell 8 $10 +123.6%
Apr 14, 2026 LONGNECKER BRENT M Sell 10 $12 +123.6%
Apr 14, 2026 LONGNECKER BRENT M Other 10 $12 +123.6%
Feb 27, 2026 Confer Ryan M. Other 9,330 $18,660 +37.5%
Feb 27, 2026 Confer Ryan M. Tax_withholding 9,330 $18,660 +37.5%
Feb 27, 2026 Berger Mark Stanley Other 7,168 $14,336 +37.5%
Feb 27, 2026 Berger Mark Stanley Tax_withholding 7,168 $14,336 +37.5%
Dec 22, 2025 Moreno Toscano Jose Antonio Other 9,000 $0 +36.8%
Dec 22, 2025 Berger Mark Stanley Other 28,500 $0 +36.8%

Politician Trades in GNPX

Date Politician Party Type Amount Since Buy
Feb 05, 2026 Tim Moore R Purchase $1K-$15K +40.3%
Dec 18, 2025 Tim Moore R Purchase $1K-$15K +26.7%

Earnings History

Date Quarter EPS Est. EPS Actual Surprise Result
Aug 12, 2026 Q2 2026
May 13, 2026 Q1 2026
Mar 31, 2026 Q1 2026 -$0.64
Mar 31, 2025 Q1 2025 -$460.02 -$286.00 +37.8% Beat
Dec 31, 2024 Q4 2024 -$437.58 -$1,265.00 -189.1% Miss
Sep 30, 2024 Q3 2024 -$2,165.46 -$1,353.00 +37.5% Beat
Jun 30, 2024 Q2 2024 -$117.30 -$150.00 -27.9% Miss

Track GNPX with ThetaPal

Get insider trade alerts, AI portfolio analysis, and options roll recommendations for GNPX and your entire portfolio.